Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presented a mixed picture. Financial performance showed modest growth with record backlog and improved EBITDA, but challenges like geographic disparities and dependence on large customers persist. Q&A highlighted uncertainties in guidance and strategic initiatives. Despite some optimism, lack of clarity on consistent growth and cautious guidance dampen sentiment, resulting in a neutral outlook.
Q4 2023 Revenue $50.2 million, up 2% year-over-year; growth attributed to a return to top line growth and increased new business.
Adjusted EBITDA $5.5 million, up over 3x year-over-year; driven by cost savings initiatives and achieving double-digit adjusted EBITDA margins.
Free Cash Flow $1.4 million; reflects disciplined expense management and cash generation.
Revenue Excluding Overage $49.3 million, up 3% year-over-year; indicates improved performance excluding the impact of overages.
Total Backlog $183 million, up 19% year-over-year; highest total backlog ever, driven by a shift towards multiyear contracts.
12-Month Backlog $127.3 million, up 6% year-over-year; reflects committed subscription revenue.
Net Revenue Retention 95%, improved from 93% in Q3 2023; reflects ongoing challenges with lower add-on sales.
Recurring Dollar Retention Rate 94%; improvement driven by a strong underlying gross retention rate.
Annualized Revenue per Premium Customer (ARPU) $96,200, up 8% year-over-year; reflects growth in premium customer revenue.
Total Revenue for Full Year 2023 $201.2 million, down from $211 million in 2022; decline primarily due to a decrease in overage revenue.
GAAP Gross Profit $30.8 million; reflects operational challenges.
Non-GAAP Gross Profit $31.6 million, up from $30.7 million year-over-year; gross margin improved to 63%.
Non-GAAP Operating Income $2.1 million, compared to a loss of $1.4 million in Q4 2022; reflects improved operational efficiency.
Net Loss per Share (GAAP) $0.06; reflects operational losses.
Non-GAAP Net Loss per Share $0.04, compared to a loss of $0.02 in Q4 2022; indicates improved performance.
Cash and Cash Equivalents $18.6 million at the end of Q4; reflects cash management efforts.
Cash Flow from Operations $4.2 million; indicates positive cash generation.
Capital Expenditures and Capitalized Software $2.8 million; reflects investment in growth initiatives.
New Product Launches: In 2023, Brightcove launched Com Studio and Marketing Studio for Enterprise, along with several important solutions for media, including Ad Monetization and Brightcove Analytics & Insights.
AI Integration: Brightcove is embedding AI across its portfolio, including in its Analytics & Insights platform and Context Aware Encoding platform, to enhance customer performance and reduce costs.
Market Expansion in Sports: Brightcove saw strong new business performance in the sports vertical, adding new logos like PGA of America and Moto America, and renewing contracts with NHL and MLS.
Geographic Revenue Distribution: In Q4, 60% of revenue was generated in North America, with 40% from international markets, highlighting a balanced geographic presence.
Cost Structure Optimization: Brightcove reduced its annualized expense run rate significantly through COGS optimization and team reductions, including a 5% headcount reduction in Q1 2024.
Backlog Growth: Total backlog grew 19% year-over-year to $183 million, the highest total backlog in the company's history, driven by a shift towards multiyear contracts.
CFO Transition: Rob Noreck will step down as CFO by the end of May 2024, initiating a transition plan for leadership.
Focus on New Business: Brightcove plans to double down on new business acquisition, particularly targeting larger accounts, as a key focus for 2024.
Macroeconomic Conditions: The company acknowledges that macroeconomic conditions currently affecting the global economy could cause actual results to differ materially from expectations.
Overage Revenue Decline: Overage declines were a significant headwind in 2023, delivering a $7 million drag to revenue. Although expected to improve in 2024, it remains a risk.
Lower Add-on Sales: Lower add-on sales were a significant headwind in 2023, impacting revenue growth. The company is hopeful for improvement but acknowledges the uncertainty.
Customer Loss Due to M&A: The company anticipates a sequential decline in revenue in Q2 due to an expected M&A-related customer loss in Asia.
Longer Sales Cycles: The company faces longer sales cycles on large deal pipelines, which may delay revenue contributions from new channel partners.
Regulatory and Compliance Risks: The company refers to material risks and uncertainties that could affect actual results, including regulatory issues, as mentioned in their SEC filings.
Cost Structure Adjustments: The company has made significant changes to its cost structure, including a 5% reduction in headcount, which may impact operational efficiency.
Market Dynamics: The company expresses caution regarding market dynamics and the timing of recovery in their add-on business, indicating potential volatility.
New Business Growth: New business increased approximately 55% year-over-year, with average annual contract values on new business up over 200% year-over-year.
Cost Structure Optimization: Significant changes to cost structure were made, including a reduction in annualized expense run rate and a 5% headcount reduction at the beginning of Q1 2024.
Product Innovation: 2023 was Brightcove's most innovative year, launching new products like Com Studio and Marketing Studio for Enterprise, and enhancing existing solutions.
AI Integration: Brightcove is committed to an AI-driven future, leveraging AI across various parts of its portfolio to improve customer performance and reduce costs.
Partnership Expansion: Several important partnerships were signed in 2023 to enhance capabilities in ad monetization and OTT distribution.
Focus on Multiyear Contracts: Executed more multiyear deals than ever, up over 25% year-over-year, contributing to a more secure recurring revenue base.
2024 Adjusted EBITDA Growth: Expecting 25% growth in adjusted EBITDA year-over-year, translating to 40% to 50% conversion to free cash flow.
2024 Revenue Guidance: Targeting revenue of $195 million to $198 million for the full year 2024.
Free Cash Flow Expectations: Expecting free cash flow to be between $5.6 million and $8 million for the year.
Q1 2024 Revenue Guidance: Targeting revenue of $49 million to $50 million for Q1 2024.
Q1 2024 Adjusted EBITDA Guidance: Expecting adjusted EBITDA to be between $4 million and $5 million for Q1 2024.
CapEx Projections: Expecting CapEx to be approximately $10 million in 2024, down from $15 million in 2023.
Free Cash Flow Guidance for 2024: Expected to be between $5.6 million and $8 million for the year, with a conversion rate of adjusted EBITDA to free cash flow at 40% to 50%.
Adjusted EBITDA Growth: Expected to grow by 25% year-over-year in 2024.
Q4 Free Cash Flow: Generated $1.4 million in free cash flow.
Cash and Cash Equivalents: Ended Q4 with $18.6 million in cash and cash equivalents.
Cost Reduction Initiatives: Implemented significant cost structure changes, including a 5% reduction in headcount.
Total Backlog: Total backlog reached $183 million, up 19% year-over-year.
Revenue Guidance for 2024: Targeting revenue of $195 million to $198 million for the full year.
Professional Services Revenue Guidance: Approximately $9 million expected for the full year 2024.
The earnings call presents mixed signals. Financial performance shows a slight revenue decline but sequential growth and improved gross margins. Despite competitive pressures and customer churn risks, optimistic guidance and strong adjusted EBITDA growth offer positive prospects. The Q&A reveals management's cautious optimism and potential ARPU growth from new products. However, the lack of clarity on inorganic growth and Q4 specifics tempers enthusiasm. Overall, the sentiment is balanced, leading to a neutral prediction for stock price movement over the next two weeks.
Basic Financial Performance: 2 (negative due to revenue decline and margin drop). Product Development and Business Update: 3 (neutral with new product launches but supply chain issues). Market Strategy: 3 (neutral with growth initiatives but unclear international plans). Expenses and Financial Health: 3 (neutral with positive EBITDA but declining retention rates). Shareholder Return Plan: 3 (neutral with no buybacks but strong cash position). Q&A insights maintain neutral sentiment. Overall, the guidance is stable, but challenges like entitlement downgrades and unclear sales figures weigh on positive aspects.
The earnings call presented a mixed picture. Financial performance showed modest growth with record backlog and improved EBITDA, but challenges like geographic disparities and dependence on large customers persist. Q&A highlighted uncertainties in guidance and strategic initiatives. Despite some optimism, lack of clarity on consistent growth and cautious guidance dampen sentiment, resulting in a neutral outlook.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.